Cargando…

Does treating with anti–PD-1 to improve glomerular health come without a cost?

Detalles Bibliográficos
Autores principales:	Jhaveri, Kenar D., Kitchlu, Abhijat, Abudayyeh, Ala
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663154/ https://www.ncbi.nlm.nih.gov/pubmed/36377662 http://dx.doi.org/10.1172/JCI164747

Ejemplares similares

Does treating with anti–PD-1 to improve glomerular health come without a cost? Reply.
por: Shankland, Stuart J., et al.
Publicado: (2022)

A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease
por: Kitchlu, Abhijat, et al.
Publicado: (2020)

Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review
por: Kitchlu, Abhijat, et al.
Publicado: (2021)

Amyloidoses in Onco-Nephrology Practice: A Multidisciplinary Case-Based Conference Report
por: Kitchlu, Abhijat, et al.
Publicado: (2023)

Atypical Anti-Glomerular Basement Membrane Disease
por: Bharati, Joyita, et al.
Publicado: (2023)

Cardio–renal service, time for a change
por: Uppal, Nupur N, et al.
Publicado: (2021)

Nirogacestat and Hypophosphatemia
por: Gudsoorkar, Prakash, et al.
Publicado: (2023)

Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
por: Kawashima, Shun, et al.
Publicado: (2022)

COVID-19 therapeutic options for patients with kidney disease
por: Izzedine, Hassan, et al.
Publicado: (2020)

Genes, COVID-19 and phenotype
por: Izzedine, Hassan, et al.
Publicado: (2021)

Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms
por: Caza, Tiffany N, et al.
Publicado: (2023)

The authors reply
por: Wanchoo, Rimda, et al.
Publicado: (2020)

Towards equations for estimating glomerular filtration rate without demographic characteristics
por: Peng, Hongquan, et al.
Publicado: (2022)

Electrolyte abnormalities in patients hospitalized with COVID-19
por: Malieckal, Deepa A, et al.
Publicado: (2021)

Utility of semi-private messaging application (WhatsApp®) for Onconephrology education: a qualitative analysis of a ‘mastermind’ chat
por: Khashu, Simoni, et al.
Publicado: (2021)

Anti-glomerular basement membrane glomerulonephritis following COVID-19 infection without clinically evident pneumonia
por: Tan, Mabel Si Hua, et al.
Publicado: (2023)

SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus Post-Nephrectomy: A Single-Center Case Series
por: Škrtić, Marko, et al.
Publicado: (2021)

A Case of Glomerulopathy Associated With Monoclonal Glomerular Basement Membrane Antibody
por: Bonilla, Marco, et al.
Publicado: (2021)

Biopsy-Proven Renal-Limited Thrombotic Microangiopathy in a Heart Transplant Recipient
por: Bharati, Joyita, et al.
Publicado: (2023)

A patient with COVID-19 and anti-glomerular basement membrane disease
por: Koc, Neriman Sila, et al.
Publicado: (2021)

A patient with COVID-19 and anti-glomerular basement membrane disease
por: Koc, Neriman Sila, et al.
Publicado: (2021)

Incidence of anti-glomerular basement membrane disease during the COVID-19 pandemic
por: Prema, K S Jansi, et al.
Publicado: (2021)

There is always glucose in normal urine: unspecific excretion associated with serum glucose and glomerular filtration rate
por: Li, Tianqi, et al.
Publicado: (2022)

Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events
por: Rao Ullur, Avinash, et al.
Publicado: (2023)

A case of seronegative anti-glomerular basement membrane disease with linear IgG deposition
por: Zhuo, Ning, et al.
Publicado: (2022)

COVID-19: Winter Is Coming
por: Brito-Azevedo, Anderson, et al.
Publicado: (2021)

Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature
por: Kasherman, Lawrence, et al.
Publicado: (2021)

A Qualitative Evaluation of Advanced Training Programs in Glomerular Diseases: Results From a Program Directors’ Survey
por: Jhaveri, Kenar D., et al.
Publicado: (2023)

Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation
por: Manson, Guillaume, et al.
Publicado: (2020)

The Coming of the Mob
Publicado: (1921)

The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
por: Wu, Dawei, et al.
Publicado: (2022)

Hints in electrocardiography for coming myocardial infarction
por: Ünlüer, Erden Erol, et al.
Publicado: (2015)

Glomerular and Tubular Functions in Transfusion-Dependent Thalassemia
por: Sookaromdee, Pathum, et al.
Publicado: (2018)

Hair Loss: A Harbinger of the Morbidities to Come!
por: Gude, Dilip
Publicado: (2012)

Providing Structure for Research Students Coming and Going
por: Campbell, A. Malcolm, et al.
Publicado: (2012)

Screening for diabetic retinopathy: New methods to come
por: Hajra, Adrija, et al.
Publicado: (2016)

When the DHOL is Beating, BHANGRA comes to the Rescue!
por: Priya, Gagan, et al.
Publicado: (2021)

Pediatric Urology in India Has Come of Age
por: Babu, Ramesh, et al.
Publicado: (2022)

CKD After 225Ac-PSMA617 Therapy in Patients With Metastatic Prostate Cancer
por: Pelletier, Karyne, et al.
Publicado: (2020)

Anti‐PD1 or anti‐PD‐L1 antibodies alone or in combination with chemotherapy first‐line treatment of advanced non‐small cell lung cancer
por: Zhang, Xuexia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6s5bsgtq2uegq495vrc7hh8sq8